G6PD and colonic neoplasm: The mTOR pathway, a key signaling pathway for initiating metabolic reprogramming,[16] is closely related to the occurrence and development of colon cancer.[56] It also promotes the expression of G6PD in an SREBF1‐dependent manner in HEK293 cells.